CEP-37251

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCEP-37251

Drug Alias NameOsteoprotegerin variant proteinOPG variantOsteoprotegerin analogueOPG variant proteinOPG analogue +[9]

ClassificationBiologics

Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitors

TargetsTumor necrosis factor ligand superfamily member 11

Therapy Area/IndicationsOsteoporosisBone Diseases, Metabolic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTeva

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCephalon

Active IndicationsN/A

Inactive IndicationsOsteoporosisBone Diseases, Metabolic

ATC CodeN/A